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Background. Multiple sclerosis (MS) is a chronic demyelinating neurological disease. Several studies have reported that
complementary and alternative therapies can have positive eﬀects against pain in these patients. Objective.T h eo b j e c t i v ew a s
to investigate the eﬀectiveness of an Ai-Chi aquatic exercise program against pain and other symptoms in MS patients. Methods.
In this randomized controlled trial, 73MS patients were randomly assigned to an experimental or control group for a 20-week
treatment program. The experimental group underwent 40sessions of Ai-Chi exercise in swimming pool and the control group
40sessions of abdominal breathing and contraction-relaxation exercises in therapy room. Outcome variables were pain, disability,
spasm, depression, fatigue, and autonomy, which were assessed before the intervention and immediately and at 4 and 10weeks
after the last treatment session. Results. The experimental group showed a signiﬁcant (P<0.028) and clinically relevant decrease
in pain intensity versus baseline, with an immediate posttreatment reduction in median visual analogue scale scores of 50% that
was maintained for up to 10weeks. Signiﬁcant improvements were also observed in spasm, fatigue, disability, and autonomy.
Conclusion. According to these ﬁndings, an Ai-Chi aquatic exercise program improves pain, spasms, disability, fatigue, depression,
and autonomy in MS patients.
1.Introduction
Multiple sclerosis (MS) is a chronic demyelinating neuro-
logical disease aﬄicting young and middle-aged adults that
impairs coordination, strength, cognition, and sensation [1].
Although treatment with immunomodulatory agents can
aﬀect the course of MS, it is not currently curable [2]. It is
the most frequent disabling neurologic disease among young
and middle-aged adults in North America and Europe [3].
Patients with MS often request complementary and
alternative medicine (CAM) in diﬀerent forms, but the
eﬀectiveness of these therapies has not been demonstrated
in MS patients [4]. A recent study found that 50–75% of
patientswithMSusedCAMbecauseitreducestheseverityof
painful symptoms and oﬀers functional improvement [1, 5].
Many MS patients reported that they turned to CAM due to
dissatisfaction with conventional pharmacological therapies
and experienced a considerable improvement in symptoms
as a result [4–6]. However, although CAM is widely used
by MS patients, there is no scientiﬁc evidence to support its
eﬀectiveness [5, 6]. The majority of MS patients use CAM
alongside their conventional treatment and report that they
receive a beneﬁt from these alternative therapies [4]. Survey
results suggest that MS patients choosing to use both CAM
and conventional medicine integrate both types of medicine
to attain a more holistic healthcare approach [3]. It is well
known that female MS patients and those with a higher
education and income are more likely to use CAM [5, 7, 8].2 Evidence-Based Complementary and Alternative Medicine
The severity of the disease may also inﬂuence the use of
CAM [9, 10]. MS patients appear to especially value mind-
body therapies, perhaps attributable to their psychological
eﬀects in reducing stress, which is known to exacerbate MS
symptoms [5, 11, 12].
Recent guidelines from the National Institute of Health
and Clinical Excellence (NICE) aﬃrmed that MS patients
should be informed of ﬁndings on the beneﬁts of certain
approachesbutdeclaredthatinsuﬃcientevidenceisavailable
to make a ﬁrmer recommendation [13]. Named techniques
includereﬂexology,massage,ﬁshoils,magneticﬁeldtherapy,
neural therapy, massage plus body work, Tai-Chi, and
multi-modal therapy [14]. MS patients also report the
therapeutic use of exercise, vitamins, herbal and mineral
supplements, relaxation techniques, acupuncture, cannabis,
and massage, mainly for the treatment of pain, fatigue, and
stress [15]. Maloni [16] reported that Tai-Chi, meditation,
andhypnotherapymayimprovethequalityoflifeandreduce
pain in MS patients by interfering with pain conduction,
producing analgesia through nociceptive pathways.
Aquatic exercise can refer to pool therapy, hydrotherapy,
or balneotherapy [17]. Hydrotherapy is frequently applied
to patients with painful neurological or musculoskeletal
alterations, [18] because the heat and ﬂoatability of the
water can block nociceptors by acting on thermal receptors
and mechanoreceptors and exert a positive eﬀect on spinal
segmental mechanisms [19]. Warm water can also increase
the blood ﬂow, helping to dissipate allogeneic chemicals
and enhance muscle relaxation. Finally, the hydrostatic
eﬀect of water can alleviate pain by reducing peripheral
edema and sympathetic nervous system activity [17, 20]. A
systematic review on crenobalneotherapy in patients with
limb osteoarthritis found that it reduced pain and improved
function and quality of life [21]. CAM is frequently used
in spa therapy in situ without exercise for various chronic
diseases, with highly positive eﬀects in middle-aged and
elderly patients [22, 23]. The main aim of this paper was to
determine the eﬀectiveness of hydrotherapy to modify pain,
quality of life, and other symptoms in MS patients.
2.MaterialsandMethods
We performed an experimental clinical trial with a control
group (MS patients receiving relaxation exercise protocol
in therapy room) and experimental group (MS patients
undergoing an Ai-Chi exercise protocol in swimming-pool).
The study period was from January 1 2009 through June 30
2010.
2.1. Participants. S t u d ys u b j e c t sw e r eM Sp a t i e n t sf r o m
the Multiple Sclerosis Association of Almeria (AEMA) in
Spain. Initial screening included medical history and pretrial
questionnaire, gathering data on age, time since diagnosis,
course of the disease, and Expanded Disability Status Scale
(EDSS). Inclusion criteria were MS diagnosis, age between
18 and 75yrs, Visual Analogue Scale (VAS) pain score >4f o r
at least two months, and EDSS ≤7.5. Exclusion criteria were
treatment with another CAM, either current or within the
previous 3 months, and relapse requiring hospitalization or
steroid treatment within the past 2 months.
Among the 198 accessible patients, 98 did not meet
the inclusion criteria and 27 refused participation in the
study. The selection of groups was balanced for the type
of medication received, using a stratiﬁcation system that
generates a sequence of letters (from a table of correlatively
ordered permutations) for each combination of categories.
Each patient was assigned a sequence of letters according
to the type of medication they were receiving, and the
diﬀerent sequences were placed in sealed envelopes that were
randomly assigned to each study group.
Informed consent was obtained from each patient before
entering the study, which was performed in accordance with
the Helsinki Declaration (2008 modiﬁcation) on research
projects and with national legislation on clinical trials (Law
223/2004 6 February), biomedical research (Law 14/2007 3
July), and patient conﬁdentiality (Law 15/1999, 13 Decem-
ber). The study was approved by the ethics and research
committee of the University of Almeria.
2.2. Procedure. The patients were randomly assigned by a
blinded researcher, using a computer-generated randomized
list, to an Ai-Chi exercise group (n = 36) or relaxation
exercise group (n = 37). Both groups received treatment
sessions twice a week for 20 weeks, on Mondays and
Thursdays for the experimental group and on Tuesdays
and Fridays for the control group. Power calculations were
carried out after 20 patients had been treated, estimating a
minimal sample size of 33 participants per group for a power
of 80% and standard deviation (SD) of 3.1.
2.3. Intervention. The Ai-Chi exercise program was con-
ducted in a swimming pool with a water temperature of
36◦C. Patients took a shower with a water temperature of
35.5◦C before entering the pool. The air temperature was
maintained at 20◦–25◦C. A single physiotherapist led all of
the Ai-Chi exercise sessions, teaching the 16 movements
that constitute this therapy (which requires no additional
material). There was a maximum of 10 participants per
session. Ai-Chi exercises, all performed in shoulder-depth
water, use a combination of deep breathing and slow,
broad movements of the arms, legs, and torso to work
on balance, strength, relaxation, ﬂexibility, and breathing.
The 16 movements or postures are designated as follows:
contemplating, ﬂoating, uplifting, folding, soothing, gath-
ering, freeing, transferring, accepting, accepting with grace,
rounding, ﬂowing, relaxing, and sustaining. Relaxation is
induced by the slow and wide movements of arms and legs
and by the focus on the breathing [24]. The principles of
Ai-Chi are Yuan (circular movements seeking internal and
external harmony), Sung (internal and external relaxation
to promote blood circulation), Ching (absence of tension in
the body), Yun (movement at a given speed that is always
controlled by the mind), Cheng (correct maintenance of
balance and posture), Shu (easy, comfortable, and relaxed
movement of the body), and Tsing (direction of thought
towards the mind, concentration). Relaxing Tai-Chi musicEvidence-Based Complementary and Alternative Medicine 3
Table 1: Demographic data at baseline.
Experimental
group
Control
group P value
Sex 26 females
10 males
24 females
13 males 0.312
Mean age: years (SD) 46 (9.97) 50 (12.31) 0.904
Age range: years 25–75 29–75
Expanded Disability
Status Scale: mean
(SD)
6.3 (0.8) 5.9 (0.9) 0.723
Years since diagnosis:
mean (SD) 10.7 (9.1) 11.9 (8.7) 0.915
Type of MS (n)
Primary Progressive 6 9 0.425
Secondary Progressive 9 12 0.406
Not known 21 16 0.318
Pain VAS score:
Mean (SD) 8.3 (1.2) 7.8 (1.6) 0.939
P value <0.05 (95% conﬁdence interval).
(album by Oliver Santi & Friends) was played to the
participants during the sessions, which lasted 60 minutes,
beginning and ending with 10 minutes of relaxation in the
water [24]. Throughout these 10min relaxation periods,
the patients performed abdominal breathing simultaneous
with contraction-relaxation exercises of muscle groups in
hands,arms,shoulders,face,neck,thighs,legs,andfeetwhile
standing in the shoulder-depth water [25].
Thesamephysiotherapistalsoledtheexercisesessionsfor
the control group, which were conducted in a therapy room
at a temperature of around 26◦C. The patients underwent
the same exercise program followed by the experimental
group during the relaxation periods (abdominal breathing
plus guided contraction-relaxation) but in supine position
on an exercise mat (tatami). No ambient music was played
during these control sessions.
2.4. Outcome Assessment. Both groups were evaluated pre-
treatment (baseline) and immediately and 4 and 10 weeks
after the treatment period by a researcher blinded to group
allocation. Primary measurement variables were pain, using
a VAS (range, 0–10 points) and the Pain Rating Index
(PRI) (0–77 points) and Present Pain Intensity (PPI) (0–
5) from the McGill Pain Questionnaire (MPQ) [26], and
disability, using the Roland Morris Disability Questionnaire
(RMDQ) (0–24) [27]. Secondary measurement variables
were the scores for: spasm VAS (0–10), Multiple Sclerosis
Impact Scale-29 (0–100) [28], Modiﬁed Fatigue Impact
Scale (physical score 0–36, cognitive score 0–40, psychosocial
score 0–40) [29], Fatigue Severity Scale (1–7), [30]B e c k s
Depression Inventory (0–63) [31], and Barthel Index (0–100
points) [32].
SPSS version 18.0 (SPSS Inc., Chicago IL) was used for
the data analyses. After a descriptive study of the demo-
graphicalvariables,thedistributionofvariableswasanalyzed
by means of the Kolmogorov-Smirnof test. An imputed
score was calculated for standardized scales missing ≤10%
of responses. Independent t-tests were used to compare
baseline demographic characteristics between participants
and dropouts and between experimental and control groups
(randomization test).
Changes in scores for anxiety, pain, depression, quality
of sleep, and quality of life were analyzed by using a 2
(Groups: experimental and placebo) × 4 (Time points:
baseline and immediately and 4 and 10 weeks after the
treatment period) repeated-measures analysis of variance
(ANOVA). A Student’s t-test for paired measures was used
to determine the eﬀectiveness of treatments. Diﬀerences
between study groups were analyzed with a Student’s t-test
forindependentsamples.P<0.05wasconsideredsigniﬁcant
in all tests.
3. Results
Out of the 198 initially screened patients, 27 refused partic-
ipation and 98 failed to meet the inclusion criteria due to
score<4inpainVAS,predicteddrugregimenchangesduring
the study, family problems, transport diﬃculties, or leaving
the region. Two patients in the control group were excluded
during the 20-week treatment period due to relapse. The
ﬁnal study sample comprised 36 patients in the experimental
group (26 females) and 35 in the control group (24 females).
TheﬂowofpatientsthroughthestudyisdepictedinFigure1.
At baseline, the groups did not signiﬁcantly diﬀer in
demographic characteristics (Table 1) or any measurement
variables (Table 2). Patients most frequently reported their
worst pain to be musculoskeletal back pain (51 with lumbar
pain and 22 with cervical pain), followed by pain in legs (n =
32), feet (n = 29), arms (n = 23), shoulders (n = 17), and
forearms (n = 13). No signiﬁcant diﬀerences in anatomic
pain distribution were found between the groups.
3.1. Primary Outcome Measures
3.1.1. Pain VAS. Immediately after the ﬁnal treatment ses-
sion (week 20 after treatment onset), the experimental group
showed a signiﬁcant reduction in pain VAS score versus
baseline (P<0.028), with a 50% reduction in pain levels
(Figure 2); the pain continued to be signiﬁcantly lower versus
baseline at weeks 24 (P<0.035) and 30 (P<0.047). The
groups signiﬁcantly diﬀered in pain VAS score at weeks 20
(P<0.044) and 24 (P<0.049). The control group showed
no signiﬁcant diﬀerences in pain VAS score versus baseline at
any time point.
3.1.2. MPQ PRI. The experimental group showed a sig-
niﬁcant pain reduction at weeks 20 (P<0.037) and 24
(P<0.043) versus baseline, and the groups signiﬁcantly
diﬀered in PRI scores (P<0.029) at these time points
(P<0.044) and (P<0.031), respectively (Table 2). At week
30, the experimental group no longer showed a signiﬁcant
pain reduction versus baseline. The control group showed
no signiﬁcant diﬀerence with baseline PRI scores at any time
point.4 Evidence-Based Complementary and Alternative Medicine
Assessed for eligibility (n = 198)
Did not meet inclusion criteria
(n = 98)
Refused to participate (n = 27)
Assessed at baseline (n = 73)
Randomized
Relaxation group (n = 37)
20-week intervention
Week 20 assessment (n = 36) Week 20 assessment (n = 35)
(n = 2) relapsed
Week 24 assessment (n = 36) Week 24 assessment (n = 35)
Week 30 assessment (n = 36) Week 30 assessment (n = 35)
Ai-Chi group (n = 36)
Figure 1: Recruitment and progress of participants through the trial.
3.1.3. MPQ PPI. The experimental group showed a sig-
niﬁcant reduction (P<0.034) in PPI at week 20. The
control group showed no signiﬁcant diﬀerence with baseline
PPI scores at any time point, and no signiﬁcant diﬀerence
between the groups wasobserved at anytime point (Table 2).
3.1.4. RMDQ. Signiﬁcant decreases in RMDQ scores were
found in both groups at weeks 20 (P<0.021, experimental
group; P<0.033, control group) and 24 (P<0.026,
experimental group; P<0.048, control group) and in the
experimental group alone at week 30 (P<0.028). Signiﬁcant
diﬀerences between groups were found at weeks 20 (P<
0.044), 24 (P<0.042), and 30 (P<0.027) (Table 2).
3.2. Secondary Outcome Measures
3.2.1. Spasm VAS. The experimental group showed a signif-
icant decrease in spasm VAS score at week 20 (P<0.039)
that was maintained at week 24 (P<0.040) but not at week
30 (P<0.067 versus week 20). The control group showed
no signiﬁcant diﬀerence versus baseline at any time point.
The groups signiﬁcantly diﬀered in spasm VAS at weeks 20
(P<0.048) and 24 (P<0.042) (Table 2).
3.2.2. Multiple Sclerosis Impact Scale-29
Psychological. Both groups showed a signiﬁcant reduction at
week 20 (P<0.009, experimental group; P<0.046, control
group) that was maintained in the experimental group at
weeks 24 (P<0.018) and 30 (P<0.024). There were
signiﬁcantdiﬀerencesbetweenstudygroupsatweeks20(P<
0.023), 24 (P<0.027), and 30 (P<0.038) (Table 2).
Physical. The experimental group showed a signiﬁcant score
r e d u c t i o na tw e e k2 0( P<0.013) that was maintained at
weeks 24 (P<0.017) and 30 (P<0.025). The control group
showed no signiﬁcant diﬀerence versus baseline at any time
point; only 6% of patients in the control relaxation program
evidenced a score improvement. There were signiﬁcant
diﬀerences between study groups at weeks 20 (P<0.014),
24 (P<0.019), and 30 (P<0.027) (Table 2).
3.2.3. Modiﬁed Fatigue Impact Scale
Physical. The experimental group showed a signiﬁcant score
r e d u c t i o na tw e e k2 0( P<0.032) that was maintained
at week 24 (P<0.038). The control group showed no
signiﬁcantdiﬀerencesversusbaseline,andonly9%evidenced
an improvement. The groups signiﬁcantly diﬀered at weeks
20 (P<0.042) and 24 (P<0.044). An improvement was
shown by 48% of the experimental group (Table 2).
Cognitive. The experimental group showed a signiﬁcant
r e d u c t i o na tw e e k2 0( P<0.038) that was maintained
at week 24 (P<0.044). The control group showed no
signiﬁcant diﬀerences versus baseline and no signiﬁcant
diﬀerence was observed between groups at any time point
(Table 2).Evidence-Based Complementary and Alternative Medicine 5
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Figure 2: Mean Pain Visual Analogue Scale scores by groups at
diﬀerent time points. Values are presented as means with error bars.
Psychological. The experimental group showed a signiﬁcant
score reduction at weeks 20 (P<0.041) and 24 (P<
0.038). The control group showed no signiﬁcant diﬀerences
versus baseline at any time point, with 27% evidencing
an improvement. No signiﬁcant diﬀerence was observed
between groups at any time point.
3.2.4.FatigueSeverityScale. Theexperimentalgroupshowed
a signiﬁcant reduction in fatigue at weeks 20 (P<0.043)
a n dw e e k2 4( P<0.046). The control group showed no
signiﬁcant diﬀerences versus baseline at any time point, with
12% evidencing an improvement. The groups signiﬁcantly
diﬀered in scores at week 24 (P<0.048).
3.2.5. Beck Depression Inventory II. The experimental group
showed a signiﬁcant reduction at weeks 20 (P<0.028) and
24 (P<0.040). The control group showed no signiﬁcant
diﬀerences versus baseline at any time point. The groups
signiﬁcantly diﬀered in scores at weeks 20 (P<0.031) and
24 (P<0.039).
3.2.6. Barthel Index. The experimental group showed a
signiﬁcant reduction at weeks 20 (P<0.047) and 24 (P<
0.049). The control group showed no signiﬁcant diﬀerences
versus baseline at any time point, with 2% evidencing an
improvement. No signiﬁcant diﬀerence was found between
the groups at any time point.
4. Discussion
In this randomized controlled clinical trial, a twice-weekly
20-week Ai-Chi aquatic exercise program signiﬁcantly
reduced pain levels in MS patients and improved fatigue,
spasms, depression, and quality of life, with no adverse
eﬀects. These beneﬁcial eﬀects lasted for 4 and 10 weeks after
the end of the program and were superior to those obtained
by control MS patients after an exercise program in a therapy
room. These ﬁrst results on the eﬀectiveness of Ai-Chi to
treat pain in MS patients are in agreement with ﬁndings of
pain reduction and mobility improvement in other patient
populations undergoing this exercise therapy [17, 33, 34].
Spasticity, which has a major impact on overall disability
in MS [35], is considerably improved by aquatic exercise,
because patients are able to perform wider voluntary move-
ments while immersed in water [17, 35]. The resulting
increase in exercise level also has a positive impact on
fatigue [36]. The provision of ambient music may have
contributed to the positive eﬀects of the Ai-Chi sessions,
by increasing motivation and distracting participants from
any discomfort produced by the physical exercise [36].
Music promotes natural rhythmic movements in the water,
enhancing mobility, and exercise with musical stimulus can
inﬂuence oscillators and timekeeper functions of the brain
[37].
One systematic review found exercise training to be asso-
ciated with an improvement in activity-related and walking
mobility in MS patients [34, 38]. Exercise is associated with
physical and psychological health beneﬁts and a reduced risk
of cardiovascular disease, diabetes, depression, and cancer
[39]. Individuals with MS should be encouraged to engage in
exerciseasanadjuvanttherapytomitigateprogressivemobil-
ity impairment, especially given the prevalence of physical
inactivity among these patients. The exercise activity in the
Ai-Chi aquatic program oﬀers beneﬁts in the treatment of
neuralandmusculoskeletaldiseasesthatmaynotbeobtained
in hydrotherapy modalities with only passive immersion,
for example, balneotherapy [17]. The experience of mobility
improvementthroughthisexerciseprogramcanbeexploited
by clinicians to promote an active lifestyle and develop
strategies to enhance their physical activity in patients with
MS. Exercise therapy improves mobility in all types of MS,
especially in secondary-progressive and primary-progressive
MS, in which pharmacological treatment is minimally
eﬀective to improve mobility and reduce disease progression
[34, 40, 41].
Ar e c e n ts t u d y[ 24] comparing the eﬀects of a 6-week
Ai-Chi aquatic exercise program and stretching exercises in
ﬁbromyalgia patients demonstrated a clinically signiﬁcant
reduction in pain and quality of sleep that lasted 4 and 12
weeks after the end of the program. However, the authors
found no evidence of clinical beneﬁts in depression, fatigue,
or mental health. In contrast, our longer Ai-Chi program
achieved a signiﬁcant reduction in depression and fatigue in
the present experimental group. Aquatic exercise programs
ranging from 3 weeks to 12 months have been studied, but
elevated dropout rates have been reported for those of longer
duration [17, 33].6 Evidence-Based Complementary and Alternative Medicine
Table 2: Median values and standard deviation values of outcome measures at each time point.
Outcome measure Group
allocation Baseline Week 20 Week 24 Week 30
Percentage change
from baseline to week
20
Pain VAS Control 7 (1.9) 6 (2.3) 6 (2.1) 6 (2.4) 23% Improvement
Experimental 7 (2.1) 3 (2.3)∗ϕ 4 (2.6)∗ϕ 5 (2.5)∗ 50% Improvement
McGill Pain
Questionnaire PRI
Control 23 (10.21) 20 (12.47) 21 (11.53) 22 (10.06) 17% Improvement
Experimental 19 (11.34) 12 (7.45)∗ϕ 14 (10.04)∗ϕ 19 (12.19) 40% Improvement
McGill Pain
Questionnaire PPI
Control 2 (1.5) 2 (1.1) 2 (1.4) 2 (1.3) 5% Improvement
Experimental 2 (1.7) 1 (0.5)∗ 1 (1.5) 2 (1.8) 40% Improvement
Roland Morris
Disability
Questionnaire
Control 9 (6.11) 5 (4.27)∗ 6 (5.33)∗ 8 (5.91) 12% Improvement
Experimental 7 (8.43) 2 (1.56)∗ϕ 3 (2.32)∗ϕ 3 (2.05)∗ϕ 100% Improvement
Spasm VAS Control 6 (3.1) 4 (4.5) 5 (3.86) 6 (2.76) 10% Improvement
Experimental 5 (2.8) 2 (4.3)∗ϕ 2 (3.9)∗ϕ 4 (3.1) 91% Improvement
MSIS-29 Physical Control 46 (18.34) 45 (17.14) 46 (19.12) 46 (15.93) 6% Improvement
Experimental 48 (15.91) 41 (12.37)∗ϕ 45 (11.25)∗ϕ 48 (12.89)∗ϕ 78% Improvement
MSIS-29
Psychological
Control 30 (23.53) 25 (19.36)∗ 27 (21.29) 29 (20.39) 37% Improvement
Experimental 34 (29.47) 21 (15.73)∗ϕ 22 (17.94)∗ϕ 24 (11.27)∗ϕ 81% Improvement
MFIS Physical Control 25 (9.41) 22 (11.03) 23 (10.34) 24 (11.17) 9% Improvement
Experimental 26 (9.02) 14 (10.37)∗ϕ 17 (9.76)∗ϕ 22 (13.81) 48% Improvement
MFIS Cognitive Control 19 (8.95) 17 (7.13) 17 (8.59) 18 (10.27) 13% Improvement
Experimental 23 (9.82) 13 (3.41)∗ 15 (6.28)∗ 17 (7.95) 61% Improvement
MFIS Psychosocial Control 5 (2.8) 4 (3.1) 4 (2.9) 5 (3.4) 26% Improvement
Experimental 5 (2.2) 2 (2.1)∗ 2 (1.3)∗ 3 (2.3) 58% Improvement
Fatigue Severity Scale Control 5 (5.1) 4 (3.9) 5 (5.2) 5 (3.8) 12% Improvement
Experimental 6 (3.1) 3 (2.2)∗ 3 (2.4)∗ϕ 4 (2.2) 39% Improvement
Beck Depression
Inventory II
Control 15 (8.68) 13 (5.91) 14 (9.01) 14 (8.93) 11% Improvement
Experimental 14 (7.72) 5 (3.2)∗ϕ 9 (4.88)∗ϕ 11 (5.92) 52% Improvement
Barthel Index Control 87 (10.34) 88 (8.92) 90 (7.65) 90 (8.73) 2% Improvement
Experimental 91 (7.12) 86 (9.23)∗ 87 (8.79)∗ 89 (9.05) 9% Improvement
Median values and standard deviations (SD). ∗Signiﬁcant change from baseline value. ϕSigniﬁcant diﬀerence between experimental and control groups.
According to Apel et al. [11], exercise therapy is the most
frequent CAM used in physiotherapy, which is an important
part of rehabilitation. Vitamins, minerals, and other supple-
ments are often added to exercise therapy. No eﬀects or only
slight improvements in MS symptoms have been reported
for electrotherapy, gemstone therapy, hematogen oxidation
therapy, homeopathy, psychotherapy, or oxygen therapy [6].
The most frequently reported beneﬁts of CAM therapies are
relaxation, improved sleep, pain reduction, spasm reduction,
muscle strength, mobility, and general well-being [5, 42].
Relaxation techniques, massage, and Feldenkrais methods
have all been associated with health beneﬁts [11].
We may have obtained better outcomes if individual Ai-
Chi sessions had been oﬀered, increasing the motivation
by allowing the patient to select the music. Study limi-
tations include the absence of an Ai-Chi group without
ambient music or the presence of a control relaxation
group with ambient music to explore the contribution of
this element. Furthermore, although the experimental and
c o n t r o ls e s s i o n sw e r eh e l do nd i ﬀerent days of the week,
we cannot guarantee that participants were blinded to the
nature of their group because they were all members of
the same association (AEMA), which may have favored an
overestimation of the eﬀects of the Ai-Chi program.
5. Conclusions
According to these results, a 20-week Ai-Chi aquatic exercise
program produces a signiﬁcant pain reduction in MS
patients that lasts for 10 weeks after the end of the program.
It also improves other MS-related symptoms, including
disability, depression, and fatigue. These eﬀects of the Ai-
Chi aquatic program were superior to those of an equivalent
exercise program in a therapy room.
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